Harmony Biosciences Holdings, Inc. HRMY
Analyst Consensus
Price Objectif
Analyst historical
| Analyste | Entreprise | Prix lors de l'analyse | Prix cible | Gain potentiel | Date de publication |
|---|---|---|---|---|---|
| Corinne Johnson | Goldman Sachs | 34.33 $ | 33 $ | -1.33 % | 10/07/2025 |
| Corinne Jenkins | Goldman Sachs | 41.49 $ | 28 $ | -13.49 % | 30/10/2024 |
| Graig Suvannavejh | Mizuho Securities | 33.6 $ | 52 $ | 18.40 % | 10/10/2024 |
| Ashwani Verma | UBS | 36.89 $ | 56 $ | 19.11 % | 10/09/2024 |
| Graig Suvannavejh | Mizuho Securities | 33.55 $ | 42 $ | 8.45 % | 08/08/2024 |
| Francois Brisebois | Oppenheimer | 30.3901 $ | 56 $ | 25.61 % | 24/06/2024 |
| Ami Fadia | Needham | 30.37 $ | 52 $ | 21.63 % | 01/05/2024 |
| Danielle Brill | Raymond James | 30.91 $ | 37 $ | 6.09 % | 30/04/2024 |
| Chris Howerton | Jefferies | 47.63 $ | 61 $ | 13.37 % | 14/10/2022 |